David C Hohn Net Worth & Insider Trades

David C Hohn - Director, Cleveland Biolabs Inc

As of March 17, 2014

What is David C Hohn's Net Worth?

The current estimated net worth of Cleveland Biolabs Inc's Director, David C Hohn, is estimated to be about $5.13K . David C Hohn owns about 9,584 units of Cleveland Biolabs Inc common stock. In the last 2 years at Cleveland Biolabs Inc, David C Hohn has sold an estimated value of $0 worth.

What is David C Hohn's Past Insider Trading?

David C Hohn's largest purchase order was 1,000 units , worth over $1.71K on April 6, 2012. In total, David C Hohn has made about 7 transactions over 2 years of their time at Cleveland Biolabs Inc. David C Hohn usually trades in June, with the busiest year in 2012. The most recent transaction was a purchase order of 1,000 units , worth over $1.61K on July 5, 2012.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David C Hohn's' Mailing Address?

  • Mailing address is C/o Cleveland Biolabs, Inc. 73 High Street Buffalo NY 14203 NY

Cleveland Biolabs Inc Executive Compensation

Name
Year
Salary
Other Compensation
Total
Langdon L. Miller 2019 $73,725 - $77,625
Langdon L. Miller 2018 $119,550 - $119,550
Andrei Gudkov 2019 $66,138 - $66,138
Andrei Gudkov 2018 $110,941 - $110,941
Christopher Zosh 2019 $92,463 $11,031 $103,494
Christopher Zosh 2018 $73,031 $9,161 $82,192
Yakov Kogan 2019 $264,323 $50,607 $314,930
Yakov Kogan 2018 $276,000 $10,800 $286,800
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1318641/000143774920023024/cbli20201029_def14a.htm

What are Cleveland Biolabs Inc's Past Insider Trades?

Cleveland Biolabs Inc's most recent insider trade came on February 27, 2015 by Randy S Saluck who bought 1,891 units worth $6.47K . In the last 8 years, insiders at Cleveland Biolabs Inc have sold an estimated value of $1.16M and bought an estimated value of $275.69K worth of shares. Insider trading is most common in June, with the busiest year in 2010. The most active traders at the company are Yakov Kogan, Chief Executive Officer,  Andrei Gudkov, Chief Scientific Officer,  and Michael Fonstein, President .

Cytocom, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1